eISSN: 2081-2841
ISSN: 1689-832X
Journal of Contemporary Brachytherapy
Current Issue Archive Supplements Articles in Press Journal Information Aims and Scope Editorial Office Editorial Board Register as Author Register as Reviewer Instructions for Authors Abstracting and indexing Subscription Advertising Information Links
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
1/2022
vol. 14
 
Share:
Send email
Share:
abstract:
Original paper

Perioperative interstitial high-dose-rate brachytherapy for keloids scar

Victoria Vera Barragán
1
,
Ana Isabel Alonso García
2
,
José Fernández García
2
,
Marta De Juan Marín
2
,
Johanna del Carmen Peña Vivas
2
,
Germán Juan Rijo
2

  1. Hospital Universitario Badajoz, Badajoz, Spain
  2. Hospital Universitario Central de Asturias, Oviedo, Spain
J Contemp Brachytherapy 2022; 14, 1: 29–34
DOI: https://doi.org/10.5114/jcb.2022.113547
Online publish date: 2022/02/18
View full text Get citation
 
Purpose
To evaluate the results of keloids treated with perioperative interstitial high-dose-rate brachytherapy (HDR-BT).

Material and methods
A retrospective review of 61 keloids in 51 patients treated with perioperative interstitial HDR-BT was performed. Keloid lesions were treated with 12 Gy in 4 fractions within 48 hours. Time between surgery and brachytherapy was less than 90 minutes. Local failure was defined as recurrence of apparent keloid or symptoms in the same place. Median age of patients was 46 years (range, 20-89 years). Keloid scars were located on the chest (41%), ear lobe (21%), back (1.6%), extremities (11.5%), and mean keloid size was 6.3 cm.

Results
With a median follow-up of 47.95 months (range, 1-96 months), the recurrence rate was 4.9%, all located on the chest. The multivariate analysis showed no statistically significant relationship between location, scar size, and previously treated lesions with the recurrence rate.

Conclusions
The treatment of keloid scars with perioperative interstitial high-dose-rate brachytherapy achieved excellent results, with a recurrence rate of only 4.9% and excellent cosmetic outcomes, suggesting that this technique might be one of the best options for treating keloids.

keywords:

brachytherapy, keloids, interstitial perioperative radiotherapy

  
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.